324 related articles for article (PubMed ID: 30815760)
1. New and Potential Treatments for Atopic Dermatitis: Biologicals and Small Molecules.
Sánchez-Borges M; Capriles-Hulett A; Ortega-Martell JA; Zubeldia IA
Curr Allergy Asthma Rep; 2019 Feb; 19(3):18. PubMed ID: 30815760
[TBL] [Abstract][Full Text] [Related]
2. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch.
Werfel T; Biedermann T
Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):446-52. PubMed ID: 26308331
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
D'Erme AM; Romanelli M; Chiricozzi A
Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
[TBL] [Abstract][Full Text] [Related]
4. Atopic dermatitis phenotypes and the need for personalized medicine.
Cabanillas B; Brehler AC; Novak N
Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):309-315. PubMed ID: 28582322
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
Kraft M; Worm M
Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
[TBL] [Abstract][Full Text] [Related]
6. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis.
Agache I; Akdis CA; Akdis M; Brockow K; Chivato T; Del Giacco S; Eiwegger T; Eyerich K; Giménez-Arnau A; Gutermuth J; Guttman-Yassky E; Maurer M; Ogg G; Ong PY; O'Mahony L; Schwarze J; Warner A; Werfel T; Palomares O; Jutel M
Allergy; 2021 Apr; 76(4):988-1009. PubMed ID: 33538044
[TBL] [Abstract][Full Text] [Related]
7. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
[TBL] [Abstract][Full Text] [Related]
8. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
9. The use of biologicals in cutaneous allergies - present and future.
Makris MP; Papadavid E; Zuberbier T
Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):409-16. PubMed ID: 25102106
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
Benzecry V; Pravettoni V; Segatto G; Marzano AV; Ferrucci S
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):261-263. PubMed ID: 32732182
[No Abstract] [Full Text] [Related]
11. [Ocular symptoms associated with dupilumab in atopic dermatitis].
Voorberg AN; Oosterhaven JAF; Wijdh RHJ; de Bruin-Weller MS; Schuttelaar MLA
Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945835
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in atopic dermatitis.
Dinakar C; Fineman SM; Tilles SA
Ann Allergy Asthma Immunol; 2018 Jan; 120(1):8-9. PubMed ID: 29273133
[No Abstract] [Full Text] [Related]
14. Towards personalized treatment in atopic dermatitis.
van der Schaft J; Thijs JL; Garritsen FM; Balak D; de Bruin-Weller MS
Expert Opin Biol Ther; 2019 May; 19(5):469-476. PubMed ID: 30768375
[TBL] [Abstract][Full Text] [Related]
15. Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
Chun PIF; Lehman H
Clin Rev Allergy Immunol; 2020 Oct; 59(2):208-219. PubMed ID: 32617839
[TBL] [Abstract][Full Text] [Related]
16. The IL-13-OVOL1-FLG axis in atopic dermatitis.
Furue K; Ito T; Tsuji G; Ulzii D; Vu YH; Kido-Nakahara M; Nakahara T; Furue M
Immunology; 2019 Dec; 158(4):281-286. PubMed ID: 31509236
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Successful Management of Severe Atopic Dermatitis.
Brar KK; Nicol NH; Boguniewicz M
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
[TBL] [Abstract][Full Text] [Related]
18. A review of dupilumab in the treatment of atopic diseases.
Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
[TBL] [Abstract][Full Text] [Related]
19. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
[No Abstract] [Full Text] [Related]
20. Real-world persistence with dupilumab among adults with atopic dermatitis.
Silverberg JI; Guttman-Yassky E; Gadkari A; Kuznik A; Mallya UG; Mastey V; Zhang H; Chen Z; Chen C; Korotzer A; Sierka D; Fenton MC; Kaur M; Jalbert JJ
Ann Allergy Asthma Immunol; 2021 Jan; 126(1):40-45. PubMed ID: 32739313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]